Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Rheumatol ; 23(4): 330-2, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15293094

ABSTRACT

This case presents a patient with hypertrophic osteoarthropathy of the lower extremities that developed secondary to congenital cyanotic heart disease. The major clinical manifestation was severe bilateral leg pain. The pain that was debilitating in nature completely resolved following a single administration of 60 mg pamidronate. Hypertrophic osteoarthropathy (HOA) is an acquired, uncommon disorder of obscure etiology. It has been described mainly in association with chronic suppurative pulmonary diseases, bronchogenic carcinoma and lung metastases, cystic fibrosis, and cyanotic congenital malformations of the heart.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Cyanosis/drug therapy , Diphosphonates/therapeutic use , Heart Defects, Congenital/drug therapy , Osteoarthropathy, Secondary Hypertrophic/drug therapy , Anti-Inflammatory Agents/administration & dosage , Bone and Bones/diagnostic imaging , Cyanosis/etiology , Cyanosis/pathology , Diphosphonates/administration & dosage , Female , Heart Defects, Congenital/complications , Heart Defects, Congenital/pathology , Humans , Infusions, Intravenous , Middle Aged , Osteoarthropathy, Secondary Hypertrophic/etiology , Osteoarthropathy, Secondary Hypertrophic/pathology , Pamidronate , Radionuclide Imaging , Radiopharmaceuticals , Technetium Tc 99m Pentetate , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...